openPR Logo
Press release

Intravenous Immunoglobulin Market Size, Share and Trends Analysis Report 2025-2034

Intravenous Immunoglobulin Market Size, Share and Trends

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2034"

The global Intravenous Immunoglobulin market is estimated to reach over USD 25.46 billion by 2034, exhibiting a CAGR of 7.00% during the forecast period.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1874

Immunoglobulins are made from a large human plasma pool obtained from at least 100 donors. The intramuscular route of administration is a traditional procedure that is no longer favoured due to its unpleasantness. In recent years, intravenous immunoglobulin has been a lifeline for people with impaired immune systems. The increasing incidences of target disorders, such as primary immunodeficiency disorders, are expected to expand the market.

The rising frequency of immunodeficiency illnesses, technological breakthroughs and investments, rising acceptance of immunoglobulin therapy, and an ageing population will likely fuel market revenue growth over the forecast period. IVIG is a sterile, concentrated set of antibodies from healthy persons injected directly into a vein. It is used to treat immune system disorders or to increase immunological response. The expense of diagnosing and treating demyelinating illness is exceptionally high.

List of Prominent Players in the Intravenous Immunoglobulin Market:
• Biotest AG
• Baxter International Inc.
• Octapharma AG
• LFB Biotechnologies
• Grifols SA
• CSL Behring
• China Biologics Products Inc.
• Kedrion Biopharma
• BDI Pharma Inc

Market Dynamics:
Drivers-
The rise in the geriatric population, the increased acceptance of immunoglobulin treatment, and the growing prevalence of immunodeficiency diseases and bleeding disorders are all key drivers driving the market growth. With new product launches and approvals, the immunoglobulin market is expected to develop in the future. IVIG therapies are in high demand for treating acquired and primary immunodeficiency illnesses since they are the most effective and only viable therapy option.

Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/1874

Challenges:
The high cost of intravenous immunoglobulin therapy will limit their usage, limiting market revenue growth to some extent over the projection period. The supply chain may be a source of concern due to a scarcity of raw materials, and various countries' severe regulatory policies would stifle business expansion. Immunoglobulin therapy, as one of the most technologically advanced therapies, is quite expensive. One of the major problems impeding the growth of the IVIG market is the high cost of medicines.

Regional Trends:
The North America Intravenous Immunoglobulin market is expected to register a major market share in revenue and is projected to grow at a high CAGR shortly. The country's sophisticated and well-structured healthcare system, a growing emphasis on research and development, and the strong presence of industry players drive market expansion.

Besides, Asia Pacific had a considerable share in the market, Increasing awareness and forthcoming opportunities for the use of immunoglobulin-based medicines to treat primary immunological deficiencies in conjunction with an ageing population.

Recent Developments:
• In March 2022, Sanofi and Seagen Inc. agreed to work exclusively to discover, develop, and commercialize antibody-drug conjugates (ADCs) targeting up to three cancer targets. Sanofi's unique monoclonal antibody (mAb) technology and Seagen's patented ADC technology will be used in the cooperation.
• In January 2022, Argenx SE, a global immunology company dedicated to improving the lives of people suffering from severe autoimmune diseases, announced that Japan's Ministry of Health, Labour, and Welfare (MHLW) had approved VYVGART (efgartigimod alfa) intravenous infusion for the therapy of adult patients with generalized myasthenia gravis (gMG) who have not answered adequately to steroids or non-steroidal immunosuppressive therapies (ISTs).

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customization/1874

Segmentation of Intravenous Immunoglobulin Market-
By Application-
• Hypogammaglobulinemia
• CIPD
• Immunodeficiency Diseases
• Congenital AIDS
• Chronic Lymphocytic Leukemia
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• ITP
• Kawasaki Disease
• Guillain-barre Syndrome
• Others
By Distribution Channel-
• Hospital Pharmacy
• Specialty Pharmacy
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get More Information :@
https://www.insightaceanalytic.com/report/intravenous-immunoglobulin-market-/1874

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intravenous Immunoglobulin Market Size, Share and Trends Analysis Report 2025-2034 here

News-ID: 4245336 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Instore Grocery Retail Market Survey Detailed Analysis and Forecast 2025-2034
Instore Grocery Retail Market Survey Detailed Analysis and Forecast 2025-2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Instore Grocery Retail Market Size, Share & Trends Analysis Report By Technology (Self-Checkout Systems, Electronic Shelf Labels, Autonomous Store Inventory Management, Digital Signage, Customer Analytics, Automated Replenishment, Others), By Product Type (Dairy Produce, Meat & Poultry, Canned & Packaged Foods, Bakery Products, Snacks & Sweets, Others), By Store Type (Supermarket & Hypermarket, Convenience Store, Specialty
Leptospirosis Market expected to Witness Huge Revenue Growth to 2034
Leptospirosis Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Leptospirosis Market Size, Share & Trends Analysis Report By Drug (Amoxicillin, Azithromycin, Cefixime, Doxycycline, Others (Ceftriaxone, Penicillin among others)), by Diagnosis (Complete Blood Count (CBC), Creatine Kinase, Liver Enzymes, Urinalysis), by Route of Administration (Oral, Parenteral, Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Region, Market Outlook And Industry Analysis 2034" The Global
Mastectomy Reconstruction Implants Market Current Scenario with Future Trends Analysis to 2034
Mastectomy Reconstruction Implants Market Current Scenario with Future Trends An …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Mastectomy Reconstruction Implants Market Size, Share & Trends Analysis Report By product (Two-Stage Implant Reconstruction {Tissue Expanders with Acellular Dermal Matrix [ADM]} [Prepectoral Breast Reconstruction Surgery, and Sub-pectoral Breast Reconstruction Surgery], and Direct-to-Implant Reconstruction), End User(Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, and Medical Spas), Region, Market Outlook And Industry Analysis 2031" The global mastectomy reconstruction
Nanomedicine Market Exclusive Report on Current Trends and Future Insights
Nanomedicine Market Exclusive Report on Current Trends and Future Insights
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nanomedicine Market Size, Share & Trends Analysis Report By Application (Therapeutics, In-Vitro Diagnostics, Drug Delivery, In-Vivo Imaging, And Implants), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type (nanoparticles, metal & metal oxide nanoparticles, liposomes, polymers & polymer-drug conjugates, hydrogel nanoparticles, dendrimers, inorganic nanoparticles, nanoshells, nanotubes, and nanodevices), Region, Market Outlook And Industry Analysis 2034"

All 5 Releases


More Releases for Immunoglobulin

Rabies Immunoglobulin Market - Dynamics and Growth Pattern
The "Rabies Immunoglobulin Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. Rabies Immunoglobulin Market report offers an in-depth analysis on segments including top companies, products, applications, revenue and regions. a number of topics including likewise market share, drivers, trends and methods. This report additionally offers insights into the latest growth and trends. It encapsulates key aspects of the market, with focus on leading
Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements …
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate? There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, South
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,
Korea Intravenous Immunoglobulin Market Analysis to 2031
Intravenous Immunoglobulin Market Outlook 2031 The global intravenous immunoglobulin market was valued at US$ 11.2 Bn in 2021 It is estimated to grow at a CAGR of 7.3% from 2022 to 2031 The global intravenous immunoglobulin market is expected to reach value of US$ 20.5 Bn by the end of 2031 Get Sample Copy of the Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1930 Overview of Intravenous Immunoglobulin Market Immunoglobulins are highly purified, sterile-specific medical therapy solutions containing gamma globulin G (IgG) in a concentration of 95% or more. These are manufactured from a highly
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of